Cutaneous DNA Damage Caused by UV-A Irradiation (DIMUVA)
Damage to DNA Caused by UV-A Irradiation: Photochemical Mechanism and Cutaneous Parameters Involved in the Formation of Cyclobutane Pyrimidine Dimers
研究概览
详细说明
Due to their capacity to damage Deoxyribonucleic acid (DNA), Ultra-Violet (UV) radiation is one of the causes of skin cancers.
Until recently, the genotoxic effects of UV-A radiation, were poorly identified, in particular their capacity to lead to the dimerization of pyrimidine bases .
It is well known that the response to UV-A and UV-B radiations is different depending on the cutaneous phototype.
Thus, the aim of this study is to determine the correlation between cutaneous phototype and the quantity and nature (CPD or oxidative lesions) of damage caused to cutaneous DNA after an ex-vivo exposure to UV-A and UV-B radiations.
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Grenoble、法国、38043
- Centre d'investigation Clinique ,University Hospital Grenoble
-
Grenoble、法国、38043
- Department of Dermatology, University Hospital Grenoble
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Male,
- Between 18 and 35 years old,
- Healthy volunteers,
- Cutaneous phototype 2 or 4 according to the Fitzpatrick classification,
- Affiliation to the French Social Security.
Exclusion Criteria:
- History of photosensibility,
- Active smoking or stopped since less than one year,
- Dermatological pathology or treatment contra-indicating cutaneous irradiation and skin biopsies,
- Any chronic pathology susceptible to interfere with the evaluations related to the protocol,
- Allergy to local anaesthetics,
- Volunteers who take drugs and/or food complements acting on oxidative stress in the 8 weeks preceding inclusion,
- Volunteers who have take paracetamol or aspirin within 7 days prior to the inclusion visit,
- Subject in exclusion period for another biomedical research study,
- Subject having exceeded the threshold of annual compensation for biomedical research.
学习计划
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:phototype 2
Volunteers with cutaneous phototype 2
|
|
|
实验性的:phototype 4
Volunteers with cutaneous phototype 4
|
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Phototype determination according to the Fitzpatrick classification Number of CPD and oxidative lesions determinated by the analysis of DNA from the skin biopsies after their ex-vivo exposure to UV-A - The CPD / Oxidative lesions ratio
大体时间:Day 0
|
Day 0
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Number of CPD and oxidative lesions determinated by the analysis of DNA from the skin biopsies after their exposure ex-vivo to UV-B.
大体时间:Day 0
|
Day 0
|
|
UV-A radiation exposure: Minimal erythemic dose - Number of CPD and oxidative lesions - CPD / oxidative lesions ratio
大体时间:Day x
|
Day x
|
|
UV-B radiation exposure: Minimal erythemic dose - Number of CPD and oxidative lesions - CPD/oxidative lesions ratio
大体时间:Day 0
|
Day 0
|
|
antioxidant status and quantity of CPD, oxidative lesions after exposure to UV-A and UV-B radiations
大体时间:day 2
|
day 2
|
合作者和调查者
调查人员
- 首席研究员:Jean-Claude BEANI, Pr、University Hospital, Grenoble
出版物和有用的链接
一般刊物
- Brash DE. Sunlight and the onset of skin cancer. Trends Genet. 1997 Oct;13(10):410-4. doi: 10.1016/s0168-9525(97)01246-8.
- Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res. 2005 Apr 1;571(1-2):91-106. doi: 10.1016/j.mrfmmm.2004.11.015.
- Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res. 2005 Apr 1;571(1-2):3-17. doi: 10.1016/j.mrfmmm.2004.09.012. Epub 2005 Jan 26.
- Douki T, Reynaud-Angelin A, Cadet J, Sage E. Bipyrimidine photoproducts rather than oxidative lesions are the main type of DNA damage involved in the genotoxic effect of solar UVA radiation. Biochemistry. 2003 Aug 5;42(30):9221-6. doi: 10.1021/bi034593c.
- Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10529-33. doi: 10.1073/pnas.90.22.10529.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- DCIC 08 13
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.